Compare Pfizer Inc (PFE) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Vanguard Dividend Appreciation Index Fund ETF trades at $237.46. The key difference: Pfizer Inc pays a 6.9% dividend while Vanguard Dividend Appreciation Index Fund ETF pays none, and Vanguard Dividend Appreciation Index Fund ETF is trading nearer its 52-week high, Pfizer Inc nearer its low. Which is the better fit depends on your goals.
| PFE | VIG | |
|---|---|---|
Market Cap | $142.14B | — |
Volume | 29,869,932 | — |
Sector | Health | — |
52-Week High | $28.56 | $239.13 |
52-Week Low | $23.29 | $204.09 |
Enterprise Value | $192.80B | — |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
VIG trades at $236.97, down 0.27% today, with a bullish technical signal from moving averages and oversold RSI_6 at 28.87. Support lies at $235, resistance at $237. The ETF focuses on dividend growth from high-quality U.S. large-caps, with a dividend of $1.00 scheduled for June 2026. Recent news highlights its role in long-term wealth building and diversification away from tech concentration.
Outlook remains positive for income-focused investors seeking stability, though reliance on dividend growth stocks exposes VIG to interest rate sensitivity and economic slowdowns. Its low expense ratio and quality screen support compounding, but yield competition from bonds or higher-dividend ETFs like VYM poses a relative value risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
